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ABSTRACT
Objective: According to the World Health Organization (WHO), palliative care (PC) should be
available to everyone suffering from life-threatening diseases and should be started early on in
the illness trajectory. However, PC is often initiated much later and is restricted to cancer
patients. There is a need for more knowledge about how early PC can be implemented in clinical
practice. The purpose of our study was to document the best evidence on methods for early
identification (EI) of palliative trajectories in cancer, chronic heart failure (CHF), and chronic
obstructive pulmonary disease (COPD) populations, and to identify preconditions for early
integration of general PC in hospitals and outcomes for patients and relatives.
Method: A comprehensive systematic review of methods, preconditions, and outcomes was
conducted via an electronic literature search of publications between 2002 and September 2012.
A final sample of 44 papers was reviewed in detail.
Results: Our study identified disease-specific and general methods for EI of patients who
might benefit from PC. Prognostication of end-stage disease based on (holistic) clinical
judgment, prognostic factors, and/or care needs are the most frequently recommended
methods. A number of interacting disease-, staff-, user-, and organization-specific barriers need
to be overcome in order to implement early integration of PC in clinical practice. Early
integration of PC may lead to better symptom management, prolonged survival, and better
quality of life.
Significance of Results:Nomethods can be recommended for routine clinical practice without
further validation. There is an urgent need to develop and evaluate methods based on the
holistic assessment of symptoms or needs. The barriers to early integration of PC are most
extensivewith regard to CHFandCOPD. Professional training and education are recommended
to facilitate early implementation of PC. The evidence about outcome is sparse and mostly
relates to cancer populations receiving specialized PC.
KEYWORDS: Early palliative care, Cancer, COPD, CHF, Hospitals
INTRODUCTION
A number of studies indicate that people with life-
threatening diseases may benefit from early pallia-
tive care (PC) (Mazanec et al., 2009; Temel et al.,
2010; Dalgaard, 2010; Murray et al., 2005). When
patients are not identified in timely fashion, the con-
sequences may include inadequate alleviation of
symptoms, unexpected emergency admissions, and
unplanned institutional death. Patients and their fa-
milies are denied the opportunity to consider their
future on an informed basis, to plan their final
time, and to prepare for death (Fischer et al., 2006;
Murtagh et al., 2004; Thoonsen et al., 2011).
In 2002, The World Health Organization (WHO)
emphasized that PC should be available to everyone
Address correspondence and reprints requests to: Karen Marie
Dalgaard, Researcher, The Danish Knowledge Centre of Palliative
Care, University of Southern Denmark, Strandboulevarden 47B,
1, 2100 Copenhagen, Denmark. E-mail: dalgaard@sdu.dk
Palliative and Supportive Care (2014), 12, 495–513.
# Cambridge University Press, 2014 1478-9515/14
doi:10.1017/S1478951513001338
495
https://doi.org/10.1017/S1478951513001338
Downloaded from https:/www.cambridge.org/core. Open University Library, on 13 Feb 2017 at 15:13:34, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
affected by a life-threatening disease, and that
measures should be initiated early on in the illness
trajectory alongside treatment to prolong life (World
Health Organization, 2002; Radbruch & Payne,
2009). Even though the debate on these objectives
has been going on for quite some time, they have
only been implemented to a limited extent in practice
(Seymour, 2012; Thoonsen et al., 2011). In the first in-
stance, this means that there are inequalities in
access to PC (Seymour, 2012). Traditionally, the tar-
get group for PC was cancer patients with advanced
disease and a short remaining lifespan (Clark & Sey-
mour, 1999; Murtagh et al., 2004; Mazanec et al.,
2009; Seymour, 2012). Patients with chronic pro-
gressive diseases still have limited access to PC. In
addition, there are indications that PC is often in-
itiated late in the trajectory (Albert, 2008; Dalgaard
et al., 2010; Gaertner et al., 2010a; Thomas et al.,
2011; Iley, 2012).
Early identification of palliative trajectories pre-
sents a number of challenges. For one thing, there
is no consensus among professionals on when the
palliative trajectory begins. The assessment criteria
may, for example, be based on the curability of the
disease, prognosis, expected remaining lifespan, pal-
liative needs, or a combination of these factors (De-
partment of Health, 2008; Lynn, 2005; Murray
et al., 2005; Thomas et al., 2011).
Another issue is that the unpredictable trajectory
of the disease may be a challenge. Although various
diseases follow a typical course, individual illness
trajectories comewith a certain amount of unpredict-
ability. Malignant diseases usually have a more
predictable progression than nonmalignant ones (Fi-
scher et al., 2006; Murtagh et al., 2004). It can there-
fore be difficult to decide when PC is appropriate for
patients with nonmalignant diseases. This unpre-
dictability can also affect how patients and relatives
experience the trajectory. They may have experi-
enced periods of severe disease followed by dramatic
improvements (Murtagh et al., 2004). It can thus be
difficult to know whether a deterioration of the dis-
ease is temporary. This unpredictability can also af-
fect the efforts of healthcare professionals. The
excessively optimistic assessment of a patient’s life
prospects by doctors and a lack of attention on the
part of healthcare professionals to decisive changes
in the patient’s condition can mean that palliative
trajectories are not identified in time (Murtagh
et al., 2004; Dalgaard et al., 2010).
A third issue is that open communication about
palliative treatment aims can be a challenge. Health-
care professionals may be reticent about inviting
patients and their families to an explicit open discus-
sion on the subject, partly because they find it diffi-
cult and partly because they are afraid of taking
away their hope (Dalgaard et al., 2010). Respect for
patients’ and families’ coping strategies can also
mean that an open discussion about PC may be inap-
propriate, particularly during the early phase of a
palliative trajectory (Murray et al., 2005).
The question is how in practice to overcome the
challenges that come with early identification of the
need for PC. A number of experts maintain that we
should nevertheless try, since early identification of
the need for PC is a precondition for timely and ade-
quate PC (Murtagh et al., 2004; Lynn, 2005; Murray
et al., 2005; Thomas, 2010; 2011; Thoonsen et al.,
2011). There is a need for more knowledge as to
how palliative trajectories can be identified and the
challenges overcome.
The aim of our study was to draw up a systematic
literature review on the best evidence of methods for
early identification (EI) of palliative trajectories for
life-threateningly ill patients with malignant and
nonmalignant diseases, and to identify preconditions
for early integration of general PC in hospitals and
the outcomes for patients and relatives. Based on
knowledge of the varied progression of diseases and
assumptions of inequality in access to palliative
measures, the study population included patients
with cancer, congestive heart failure (CHF), and
chronic obstructive pulmonary disease (COPD).
METHODS
This systematic reviewwas synthesized from the best
evidence available. In September 2012, a compre-
hensive literature search was undertaken of the
Cochrane Library, PubMed, EMBASE, CINAHL,
PsychINFO, and SveMedþ databases, as well as rel-
evant international websites covering the period
2002 to 2012. Inclusion criteria were: peer-reviewed
articles and evidence-based clinical guidelines, writ-
ten in English, Danish, Norwegian, and Swedish; re-
porting studies of adult patients with cancer, CHF,
and COPD in Western locations (United States,
Canada, Australia, New Zealand, and European Un-
ion [EU] countries), with a focus on general PC in
hospitals.
Devising a search strategy was very challenging
due to the lack of MeSH (medical subject heading)
terms for this topic area. Our librarian developed
the search strategy together with the research
team. Table 1 summarizes the search terms em-
ployed. Given the diffuse search terms involved,
this generated 2,369 titles. The titles and abstracts
were screened to exclude articles that were clearly
not pertinent. After removal of duplications, 97
papers were read in full, 34 of which met the in-
clusion criteria. Further hand searches were under-
taken by screening the reference lists and citations
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of included papers (which yielded 13 papers), and in-
ternational websites were screened for evidence-
based clinical guidelines (yielding 8 guidelines). A
total of 55 papers met the study criteria (Fig. 1 out-
lines this process). Finally, each paper was assessed
regarding its methodological standard and validity.
Checklists based on objective criteria were employed
to increase the transparency and reproducibility of
the assessment. For assessment of quantitative
studies and systematic reviews, checklists based on
the method for evaluating research and guideline
evidence (MERGE) were utilized (Sundhedsstyrel-
sen, 2004). Qualitative methods were assessed using
the Critical Appraisal Skills Programme (Critical
Appraisal Skills Programme (CASP) (2010)). Clinical
guidelines followed the Appraisal and Guidelines for
Research & Evaluation (AGREE) instrument
(AGREE Collaboration, 2003), which is an interna-
tionally recognized instrument for critical assess-
ment of clinical guidelines. Papers of low
methodological quality (few or no criteria met), as
well as clinical guidelines that could not be rec-
ommended according to AGREE (or where there
was doubt as to whether or not they could be rec-
ommended), were excluded (n ¼ 11). A number of
“systematic reviews” were classified as “reviews”
due to a lack of systematic approach. The final sample
included 44 papers.
Our review addressed different objectives, best
answered with different methods. Due to the hetero-
geneity of the sample, the papers included were not
rated according to evidence hierarchies (Polit &
Beck, 2008). In our study, best evidence was based
on findings from methodologically appropriate and
valid systematic reviews (6), quantitative (14) and
qualitative (6) studies, reviews (9), and evidence-
based clinical guidelines (9).
RESULTS
The final sample of 44 reviewed papers is summar-
ized in Tables 2–7 according to primary focus. The re-
sults can be categorized as follows: methods specific
for cancer, CHF, and COPD; general methods for EI
of palliative illness trajectories; preconditions for
Table 1. Summary of search strategy
Diseases
† Pulmonary Disease, Chronic Obstructive OR
Neoplasms OR Heart Failure
AND End of Life
† Terminal Care OR Palliative Care OR Terminally Ill
OR Critical illness
AND Place
† Hospitals OR Hospital Units OR Hospitalization OR
Hospital* (FT)
AND Identification
† Patient Transfer OR Needs Assessment OR Health
Status Indicators OR Patient Care Planning OR
Patient Selection OR Referral and Consultation OR
Outcome and Process Assessment OR Disease
Progression OR Prognosis OR Delivery of Health Care
OR Critical Pathways OR Continuity of Patient Care
OR Health Services Accessibility OR Health Services
Needs and Demand
The result of the search above was combined with the
searches below with the Boolean operator AND in
various ways
Time
† Timely Identification (FT) OR Early Identification
(FT) OR Time Factors
Preconditions
† Family OR Caregivers OR Quality of Life OR Attitude
to Death
The search terms varied slightly for each database
searched.
Fig. 1. Selection of papers.
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Table 2. Methods for early identification of palliative trajectories in cancer
Study Population Aims Design Key Findings
Gaertner et al.
(2012),
Germany
Hemato-oncological
malignancies (862)
To assess at what point in the disease
trajectory integration of PC can be
achieved
To assess interventions delivered by
PCST
Chart review,
retrospective
Advocate for the provision of disease-specific
guidelines to institutionalize early integration of
PC
Gaertner et al.
(2011b),
Germany
19 hemato-oncological
malignancies without
curative treatment
options
To propose and implement an effective
approach to early integration of PC
Expert consensus about
interdisciplinary
disease-specific SOP
SOPs were developed for 19 malignancies: A disease
specific point in each disease trajectory to initiate
early integration of PC (“green flags”)
Differentiation of PC assignments (“red flags”)
Gaertner et al.
(2011a),
Germany
Breast cancer patients
(83)
To evaluate the effect of institutional
recommendations of early
integration of PC
To assess the point in the disease
trajectory for integration of PC
Chart review,
retrospective
Administrative directives and PC structure) did not
suffice to implement early integration of PC
Gaertner et al.
(2010b),
Germany
Lung cancer patients
without curative
treatment options
To develop disease-specific SOP,
provide concise definitions of PC
structures and competencies to
overcome barriers of early
integration
Expert consensus about
SOP for lung cancer,
reflections on pilot study
Disease-specific guidelines for early integration of PC
into lung cancer therapy by defining triggers, PC
parallel to anti-cancer therapy, specify PC
assignments and infrastructure
Gaertner et al.
(2010a),
Germany
Lung cancer patients
(131)
To assess when patients were provided
PC and whether earlier integration
could be achieved
Chart review,
retrospective
The institutional adaptation of “The early integration
approach” did not suffice to implement early
integration of PC
Glare & Sinclair
(2008),
Australia
Main focus: advanced
cancer
To understand the impact an
formulation of prognosis in patients
with advanced cancer
Palliative care, review Cultivate subjective judgment skills in formulating
and communicating survival prediction combined
with tools
Gripp et al.
(2007),
Germany
Cancer patients referred
to palliative
radiotherapy (216)
Two physicians
The institutional tumor
board
To study how survival relates to
subjective prediction, objective
prognostic factors and individual
psychological coping
Cohort, retrospective Physicians’ survival estimates unreliable; self-
reported emotional distress and objective
prognostic factors may improve the accuracy
Maltoni et al.
(2005), Europe
(EAPC)
Advanced cancer
patients, median
survival .90 days
To provide evidence-based clinical
recommendations on the use of
prognostic factors to determine
length of survival
Systematic review Prognostication of life expectancy is significant (six
recommendations developed)
Combine clinical experience and evidence from the
literature
NCCN (2011),
USA
Cancer patients in their
last 12 months of life
To develop PC guidelines to facilitate
appropriate integration of PC into
oncology practice
Clinical guidelines based
on evidence and
consensus
Procedures for screening based on specific clinical
situations
Positive screening integrating PC
Negative screening re-screening at regular
intervals
Trajkovic-
Vidakovic et al.
(2012),
Netherlands
Cancer patients in the
palliative phase
To determine the prognostic meaning
of symptoms in relation to three
progressive stages of the palliative
phase
Systematic review Symptoms with independent predictive value are
confusion, anorexia, fatigue, cachexia, weight loss,
dyspnea, and dysphagia
PC ¼ palliative care; PCST ¼ PC hospital support team; SOP ¼ standard operating procedures; EAPC ¼ European Association of Palliative Care.
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Table 3. Methods for early identification of palliative trajectories in CHF
Study Population Aims Design Key Findings
Albert (2008),
USA
Advanced CHF To describe current issues that limit
referral to PC
Invited review Prognostication a problem in CHF
CHF guidelines have limited focus on EoLC
Research needed to overcome gaps in
knowledge
Allen et al.
(2008), USA
122 CHF ambulatory
patients
To quantify expectations for survival in
CHF
To compare patient expectations to model
predictions
To identify patient-related factors
associated with discrepancies
Prospective face-to-face
survey with quantitative
and qualitative questions
Patients overestimate life expectancy relative
to model predicted, which may affect
decision making regarding EoLC planning
Ezekowitz et al.
(2011),
Canada
105 patients
diagnosed with
CHF in an
outpatient clinic
To identify CHF patients requiring PC
To asses the utility of PC questionnaires
ESAS or PPS with KCCQ or NYHA
functional class
Cohort, prospective Modest correlation with NYHA functional
class and KCCQ assessment with the PPS
and ESAS
Jaarsma et al.
(2009), Europe
(ESC)
CHF To address the issue of PC in CHF to
increase awareness of the need for PC
Aworkshop statement,
synthesis of
presentations and
discussions
CHF disease trajectory and triggers for
initiating PC goals and discussion
James et al.
(2010), USA
214 inpatients with a
discharge diagnosis
of CHF
To determine if SHFM can identify CHF
inpatients who would benefit from
timely PC
Cohort, retrospective and
prospective
Medical records
63% with life expectancy ≤1.5 years would
have received timely PC had SHFM been
used
Levy et al.
(2006), USA
Model derived in a
cohort of 1125 in
patients with CHF
To develop and validate a multivariate
risk model to estimate survival of CHF
patients to predict 1-, 2-, and 3-year
survival
The SHFM provides an accurate estimate of
1-, 2-, and 3-year survival with use of
clinical, pharmacological, device, and
laboratory characteristics
Rector et al.
(2006), USA
769 patients with
primary diagnosis
of CHF
To evaluate the predictive validity of a
risk score (1-year mortality)
Cohort, retrospective,
medical records
The results support the validity of the risk
score
Task Force . . .
(2008), Europe
Acute and chronic
CHF
To update guidelines for the diagnosis,
assessment and treatment of acute and
chronic heart failure
Guidelines based on
evidence and expert
consensus
Identify patients suitable for PC, prognosis of
end-stage CHF
Triggers: clinical features and clinical
judgment
Task Force . . .
(2012), Europe
Acute and chronic
CHF
To update guidelines for the diagnosis,
assessment, and treatment of acute
and chronic CHF
Guidelines based on review
and expert consensus
Difficult to identify a specific timepoint for
considering PC
Triggers: Clinical, biological, and functional
features and clinical judgment
Zambroski
(2006), USA
Advanced CHF
(NYHA, stage D)
To solve the barrier of lack of prognostic
indicators
Clinical review Recommended methods: adopt NIH criteria
for end of life
Chronic disease(s) or symptoms or functional
impairment and care needs
CHF ¼ congestive heart failure; PC ¼ palliative care; EoLC ¼ end-of-life care; ESAS ¼ the Edmonton Symptom Assessment Scale; PPS ¼ the Palliative
Performance Scale; KCCQ ¼ the Kansas City Cardiomyopathy Questionnaire; NYHA ¼ the New York Heart Association Functional Class; SHFM ¼ Seattle Heart
Failure Model; ESC ¼ European Society of Cardiology; NIH ¼ National Institutes of Health.
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early integration of general PC in hospitals; and out-
comes. The main categories are presented below.
Methods for Early Identification of
Palliative Trajectories in Cancer Patients
(see Table 2)
Prognostication of Advanced Cancer
Historically, prognostication has been of great impor-
tance in identification of palliative trajectories, as
the palliative target group was confined to those
with incurable illness and a short expected remain-
ing lifespan (World Health Organization, 1990).
Prognostication is not explicitly linked to EI of pallia-
tive trajectories, but rather with clinical decision
making, discussions about therapeutic interventions
and quality of life (QoL), and a patient-centered ethi-
cal approach to enhance autonomy and help families
to make informed choices (Maltoni et al., 2005; Glare
& Sinclair, 2008; Trajkovic-Vidakovic et al., 2012).
Prognostication can be based on clinical prediction
of survival (CPS), prognostic scores, prognostic indi-
cators, biological parameters, and psychological cop-
ing. CPS is a useful and valid tool, but it should be
combined with other prognostic factors due to vari-
ation in the accuracy of physicians’ judgments (Mal-
toni et al., 2005; Gripp et al., 2007; Glare &
Sinclair, 2008; Trajkovic-Vidakovic et al., 2012).
Typically, prognostic scores focus on statistical me-
dian survival data, with little relevance to the indi-
vidual patient (Glare & Sinclair, 2008). However,
clinicians can use prognostic scores to prepare a gen-
eral prognosis and CPS to refine an individual prog-
nosis (Maltoni et al., 2005; Glare & Sinclair, 2008).
The two most validated and used scales, the Pallia-
tive Prognostic Index (PPI) and the Palliative
Prognostic Score (PaP), are especially useful in pre-
dicting short-term survival (,3 months) and there-
fore less relevant for EI (Glare & Sinclair, 2008;
Trajkovic-Vidakovic et al., 2012). Prognostic scores
are available that are useful for predicting survival
of greater than three months (Glare & Sinclair,
2008). A full discussion of these issues is beyond
the scope of the present paper.
Clinicians can employ patient-related prognostic
indicators and a number of clinical signs and symp-
toms that have proved to be associated with life ex-
pectancy. There is strong evidence for performance
status, clinical symptoms associated with cancer
anorexia–cachexia syndrome, dyspnea, and delirium
(Maltoni et al., 2005). However, these indicators are
especially relevant for terminal pathways (survival
Table 4. Methods for early identification of palliative trajectories in COPD
Study Population Aims Design Key Findings
Iley (2012),
UK
End-stage COPD How to recognize end-stage
COPD and incorporate
active PC and EoLC
discussions
Review HCP has to overcome
difficulties due to
identifying end-stage COPD
and EoLC discussions
Method: incorporate GSF,
training and education
Seamark
et al.
(2007),
UK
COPD Identify patients in the last
year of life, time for active
treatment and supportive
care, and EoLC
discussions
Review Prognostication difficult;
recommend methods for
identification; clinical
judgment by use of the
Surprise Question and three
disease-specific clinical
indictors
Trueman &
Trueman
(2011), UK
End-stage COPD Recognition of the palliative
phase of COPD
Review Use tools to help clinicians
recognize the palliative
phase of COPD combined
with training in
communications skills
Pinnock
et al.
(2011), UK
End-stage COPD
patients (21)
Informal (13) and
professional
carers (18)
To understand the
perspectives of people
with COPD as their
illness progress, and of
informal and
professionals caregivers
To inform provision of care
for COPD patients
Serial qualitative
interviews (93)
with patients and
nominated carers
during 18 months
A point of transition to PC is
meaningless and
impractical in COPD;
propose holistic assessment
of supportive and palliative
care needs triggered at key
disease milestones along a
lifetime journey with COPD
COPD ¼ chronic obstructive pulmonary disease; UK¼ United Kingdom; PC ¼ palliative care; EoLC ¼ end-of-life care
discussions; HCP ¼ healthcare professional; GSF ¼ Golden Standards Framework.
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Table 5. General methods for early identification of palliative trajectories
Study Population Aims Design Key Findings
Boyd &
Murray
(2010), UK
Patients with advanced long-
term conditions, and/or
progressive life-limiting
illness
To offer guidance about recognizing
EoL transitions by the use of
clinical judgment
Review Pragmatic clinical criteria:
Identify target group and use of the Surprise
question
One or more clinical indicator(s)
Two or more disease related indicators
Fischer et al.
(2006), USA
Patients admitted to general
medical wards or medical
ICU (sample size 873)
To validate a set of prognostic criteria
to identify patients with limited life
expectancy (,1 year) who might
benefit from PC
Retrospective chart review The CARING criteria were highly predictive
of death at one year in hospitalized
veteran population at the time of hospital
admission
Highet et al.
(2012), UK
People with advanced,
incurable conditions; or at
risk of sudden, acute
deterioration
A tool to identify the target group for
assessment and care planning
Clinical guidelines
Supportive & palliative care
indicator tool
Triggers: general clinical indicators,
disease-specific clinical indicators, the
Surprise Question
Lunney et al.
(2003), USA
4190 descendants .65 year,
died from cancer, organ
failure (CHF, COPD), frailty
and sudden death
To determine if functional decline
differs among four types of illness
trajectories: sudden death, cancer,
organ failure, and frailty.
Cohort, prospective (follow-up six
years)
Baseline in person interview
Follow up 6–10/year
Interview within last year of life
Four empirical trajectories of functional
decline
Main et al.
(2006), UK
All patients with advanced life-
limiting illness admitted to
hospital
To develop and implement an
integrated care pathway
Clinical guidelines
The Supportive Care Pathway
A holistic document for all aspects of care,
including entry criteria to the pathway
(survival .12 months)
Murray et al.
(2005), UK
Cancer, organ failure (COPD,
CHF), frail elderly
Review currently described illness
trajectories at the end of life and
draw clinical implications
Clinical review Three typical trajectories, with varying
needs
Awareness may help clinicians to meet the
multidimensional needs of patients
Thomas
(2010), UK
Cancer, organ failure, frailty/
dementia
A tool to assist generalist clinicians
with timely identification of
palliative patients
The GSF clinical guidelines
The PIG
To identify patients within the final 12
months. of life
Triggers: the Surprise Question, general
indicators,
Disease-specific indicators
Individual needs based coding
Thomas
(2011), UK
Cancer, organ failure, frailty/
dementia
A tool to assist generalist clinicians
with timely identification of
palliative patients
GSF Clinical guidelines
The PIG
To identify patients within the final 12
months of life
Triggers: the Surprise Question, general
indicators,
Disease-specific indicators
Individual needs based coding
Weissman &
Meier
(2011), USA
Patients with a potentially life-
limiting or life-threatening
condition, disease or
disorder
To select criteria to identify patients
at high risk for unmet PC needs
To improve general PC
CAPC clinical guidelines
Consensus report from CAPC
PC screening assessment tool:
Primary and secondary criteria at
admission to hospital
Primary and secondary criteria for daily
rounds
UK ¼ United Kingdom; EoL ¼ end of life; PC ¼ palliative care; CHF ¼ chronic heart failure; COPD ¼ chronic obstructive pulmonary disease; PIG ¼ prognostic indicator
guidance; GSF ¼ golden standards framework; CAPC ¼ Center to Advance Palliative Care; PC ¼ palliative care.
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Table 6. Preconditions for early integration of palliative trajectories in cancer, CHF, and COPD
Study Population Aims Design Key Findings
Barclay et al.
(2011), UK
CHF patients and their
HCP
To review the literature concerning EoLC
conversations: Prevalence, preferences
for their timing and content, facilitators,
and blockers
Systematic review EoLC is rarely discussed; focus is largely on
disease management; patient preferences
vary; HCPs are unsure, fearing alarm and
destroying hope; wait for cues from patient
Boyd et al.
(2009), UK
Advanced CHF patients
(36), carers (30), & HCP
(62) Patients, carers, key
professionals (32)
To evaluate the key components of services
for people with CHF and recommend how
it may be delivered in line with UK
policies on long-term conditions EoLC
Serial interviews (162)
Focus groups
interviews (4)
Prognostic uncertainty hindered consistent
proactive PC; patients needing PC should
be identified and managed using
pragmatic criteria that include proactive
shift in care goals
Dalgaard
et al.
(2010),
Denmark
Incurable ill hematological
cancer patients, relatives,
nursing staff and
physicians
To describe the significance of
identification and explicit
communication of clinical phases in
incurable illness trajectories
Participant
observation and
informal interview
Focus groups, HCP
interviews (4)
Identifying and explicit communication of
transitions in incurable illness trajectories
are important preconditions for provision
of quality PC
Green et al.
(2010), UK
CHF patients To examine the extent of communication
surrounding the potential transition to
PC
Narrative review Themes: barriers to effective communication;
patient characteristics; achieving effective
communication
Knauft et al.
(2005),
USA
Oxygen-dependent COPD
patients (115)
Physicians (89)
To identify barriers and facilitators to
patient/physician communication about
EoLC
Structured interview
with patients
Mail survey with
physician
A minority of patients (32%) discuss EoLC
with their physician
Identified a number of specific patient and
physician endorsed barriers and
facilitators relevant to individual patient–
physician pairs
Momen et al.
(2012), UK
COPD patients and their
HCP
To address issues about EoLC discussions:
prevalence, preferences for timing and
content, barriers and facilitators
Systematic review EoLC are rarely discussed. Patient
preferences varies
HCPs acknowledge the value of
conversations, but find them difficult;
many prefer patients to initiate them
Selman et al.
(2007), UK
CHF patients, NYHA class
III/IV(20)
Family carers (11)
PC and cardiology clinicians
(12)
To formulate recommendations for
improving EoLC
To generate data on patient and carer
preferences
To investigate communication on EoLC
issues
Semistructured
qualitative
interviews for each
sample
Recommendations: sensitive discussions of
EoLC issues; mutual education of staff;
referral criteria and care pathways
Spathis &
Booth
(2008), UK
Advanced COPD To provide an evidence-based approach to
overcome barriers to good EoLC
Systematic review Improving the quality of EoLC lies in
overcoming barriers: prognostication
difficulties and inadequate
communication, and improve ACP
discussions, education, and PC service
UK ¼ United Kingdom; CHF ¼ chronic heart failure; COPD ¼ chronic obstructive pulmonary disease; HCP ¼ healthcare professionals; EoLC ¼ end-of-life care;
PC ¼ palliative care; COPD ¼ chronic obstructive pulmonary disease; NYHA ¼ the New York Heart Association functional class; ACP ¼ advanced care planning.
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Table 7. Outcome of early integration of palliative trajectories for patients and relatives
Study Population Aims Design Key Findings
Temel
et al.
(2011),
USA
151 ambulatory
patients with newly
diagnosed NSCLC
To assess the accuracy of patient
perceptions of prognosis and goals of
cancer therapy
To examine the effect of early PC on
patient illness perception over
6 months
To explore if changes in illness
perceptions were associated with
EoLC
RCT: compare early PC/
standard oncology care vs.
standard oncology care alone
Many (69.4%) newly diagnosed patients have
an inaccurate perception of their prognosis;
early PC significantly improves patient
understanding of prognosis over time
Temel
et al.
(2010),
USA
151 ambulatory
patients with newly
diagnosed NSCLC
To examine if patients receiving early
PC experience better QoL, lower
rates of depressive symptoms and
less aggressive EoLC
RCT: compare early PC and
standard oncology care vs.
standard oncology care alone
Early PC led to significant improvements in
QoL and mood, less aggressive care at the
end of life but longer survival compared with
patients receiving standard care alone
Wright
et al.
(2008),
USA
Patients with advanced
cancer and informal
caregivers (332
dyads)
To examine the association between
EoL discussions and medical care,
patient psychological distress, QoL,
and caregiver bereavement
Cohort, prospective,
longitudinal; baseline
structured interview patients,
interview caregivers
postmortem
EoL discussions were associated with less
aggressive medical care and earlier hospice
referrals; Aggressive care is associated with
poorer patient QoL and worse bereavement
adjustment
NSCLC ¼ non-small-cell lung cancer; PC ¼ palliative care; EoLC ¼ end-of-life; RCT ¼ randomized controlled trial; QoL ¼ quality of life; EoL ¼ end-of-life care.
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,3 months). Performance status, nutritional status,
dyspnea, confusion, and abnormal laboratory tests
(leukocytosis, lymphocytopenia, and elevated C-reac-
tive protein [CRP] levels) are more important in ad-
vanced cancer (Maltoni et al., 2005; Glare &
Sinclair, 2008). Prognostication in less advanced can-
cer is typically based on tumor-related indicators
(Maltoni et al., 2005; Gripp et al., 2007; Trajkovic-Vi-
dakovic et al., 2012).
Trajkovic-Vidakovic and colleagues (2012) descri-
bed the prognostic meaning of symptoms in relation
to three progressive stages of the palliative phase:
(1) disease-directed (advanced cancer, predicted
survival 3–12 months); (2) symptom-oriented (far
advanced, predicted survival ,3 months), and (3)
terminal (death imminent). There appeared to be
important differences between those relevant to
disease-directed and symptom-oriented palliation.
Confusion, dyspnea, and fatigue were less relevant
in disease-directed palliation.
The prognostic capacity of subjective indicators
such as QoL or other psychological parameters
is somewhat contradictory but relevant in earlier
stages of the disease (Maltoni et al., 2005). Gripp
et al. (2007) studied howCPS, objective prognostic in-
dicators, and psychological coping relate to survival.
They found a strong impact of psychological distress,
namely, depression and anxiety, on survival. Their
conclusion was that self-reported emotional distress
may improve prognostic accuracy.
Diagnosis-Specific Clinical Assessment
A German research group examined how early inte-
gration (EI) of PC can be implemented in routine can-
cer care (Gaertner et al., 2010a; 2011a; 2012) and
concluded that identifying the expected survival
time of a specific patient is problematic, and that
the use of symptom burden as the only trigger for in-
tegration of PC may lead to excessively late PC refer-
rals. They advocated that clinical assessment be
based on diagnosis-specific clinical guidelines
(Gaertner et al., 2010b; 2011b) and that palliative
care be integrated when the therapeutic options for
each disease are no longer curative (i.e., life-threa-
tening, incurable and progressive disease). They
have defined diagnosis- and stage-specific points at
which PC should be integrated into the clinical path-
way of 19 hemato-oncological malignancies.
Clinical Holistic Screening
The National Comprehensive Cancer Network
(NCCN) developed guidelines to facilitate the in-
tegration of PC for cancer patients during their
last year of life (National Comprehensive Cancer
Network, 2011). They recommended screening proce-
dures based on specific clinical situations: uncontrol-
led symptoms; moderate to severe distress related to
cancer diagnosis and/or therapy; serious comorbid
physical and psychosocial conditions; life expectancy
greater than 12months based on objective prognostic
indicators (poor performance status, CNS metasta-
sis, delirium, superior vena cava syndrome, spinal
cord compression, cachexia, malignant effusions, li-
ver failure, kidney failure, or other comorbid con-
ditions); patient/family concerns about the course
of the disease and decision making; and when the
patient/family requests PC. They suggested that pal-
liative care should be integrated into general oncol-
ogy care when patients meet at least one screening
criterion.
Methods for Early Identification of
Palliative Trajectories in CHF Patients
(see Table 3)
Prognostication of End-Stage CHF
A number of prognostic approaches to EI of pallia-
tive trajectories in CHF patients have been descri-
bed. There is a review linking the identification of
end-stage CHF and the timing for PC (Albert,
2008). Palliative care begins when a person is diag-
nosed with a life-threatening or debilitating con-
dition. It is difficult to know when CHF will
become debilitating, but no single marker has been
found to be more useful than objective and subjec-
tive clinical assessment based on prognostic indi-
cators such as poor outcome indicators, activities of
daily living, impaired nutrition, and New York
Heart Association (NYHA) functional status IV (Al-
bert, 2008).
Prognostic scores can be employed to predict survi-
val (Levy et al., 2006; Rector et al., 2006; James et al.,
2010). The Seattle Heart Failure Model (SHFM) pro-
vides an accurate estimate of 1-, 2-, and 3-year survi-
val with the use of clinical and pharmacological
devices and laboratory variables (Levy et al., 2006,
p. 1426). Use of the SHFM in individual clinical situ-
ations is not explicitly linked to early identification of
palliative trajectories. A model has been developed
and validated among outpatients, but it was vali-
dated within a cohort of 214 inpatients to determine
whether the SHFM could identify patients with a
lifespan of less than 1.5 years who might benefit
from PC (James et al., 2010). Nevertheless, this
model fell short of providing an accurate measure of
life expectancy when used in this fashion.
Validation of a risk score for dying within one year
of admission for CHF based on vital clinical signs,
laboratory tests, and comorbidity also indicates that
prediction of individual deaths is far from perfect
(Rector et al., 2006).
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One study compared patients’ subjective self-
assessment of life expectancy with model predictions
using the SHFM (Allen et al., 2008). Patients tend
to overestimate life expectancy regardless of the ob-
jective severity of their heart failure. Guidelines
developed by the European Society of Cardiology
(ESC) recommend a combination of objective indi-
cators and clinical judgment (Task Force for the Di-
agnosis. . ., 2008; 2012; Jaarsma et al., 2009). The
ESC describes the characteristic trajectory for pro-
gressive CHF in three stages: (1) chronic disease
management (NYHA l-III), (2) supportive and pallia-
tive care phase (NYHA III-IV), and (3) terminal care
phase (Jaarsma et al., 2009). PC is relevant in stages
2 and 3, and should be introduced during stage 2.
TheESChas also identified points on theCHF trajec-
tory that could act as triggers for PC discussions.
These triggers are based on clinical, biological, and
functional factors and clinical judgment: frequent
admission to hospital or other serious episodes of de-
compensating despite optimized treatment; heart
transplantation and mechanical circulatory support
ruled out; chronically poor QoL with NYHA class
IV symptoms; cardiac cachexia/low serum albumin;
dependence in most activities of daily living; and
clinically judged to be close to the end of life (Task
Force for the Diagnosis. . ., 2012).
Integrated Approach
An integrated approach combines identification of
patients with advanced CHF and care needs (Zam-
broski, 2006). The rationale is that patients with ad-
vanced CHF must be provided with PC concurrently
with life-prolonging intervention, as sudden death
can occur at any time, during any phase. Advanced
CHF can be identified by adopting the National Insti-
tutes of Health (NIH) criteria to define end of life.
First, the person must have (a) chronic disease(s) as
well as symptoms or functional impairment that
persist(s) or fluctuate(s). Second, there must be symp-
toms or impairments that result from the underlying
irreversible disease that require formal or informal
care and that can lead to death. Patients meeting
these criteria must receive palliative care.
Symptom Assessment
A study by Ezekowitz and colleagues (2011) links clin-
ician- and patient-assessed symptoms and palliative
care needs. The principal objective was to assess the
utility of PC questionnaires (the Edmonton Symptom
Assessment Scale [ESAS] or the Palliative Perform-
ance Scale [PPS]) as a supplement to CHF-validated
questionnaires (the Kansas City Cardiomyopathy
Questionnaire [KCCQ] or TheNewYorkHeartAssoci-
ation [NYHA] Functional Class), as traditional CHF
scores alone have not proved clinically useful. This
study could not confirm that the PPS or the ESAS
was the ideal questionnaire for identifying patients re-
quiring PC. The PPS and ESAS may serve as useful
screening questionnaires for symptoms not captured
in traditional CHF questionnaires.
Methods for Early Identification of
Palliative Trajectories in COPD Patients
(see Table 4)
Prognostication of End-Stage COPD
Predicting the prognosis in COPD is difficult due to
the uncertain illness trajectory (Seamark et al.,
2007; Trueman & Trueman, 2011; Iley, 2012). Three
papers linked timely transition to PC and end-stage
COPD, defined as patients with severe COPD enter-
ing the final 12 months of life (Seamark et al., 2007;
Trueman & Trueman, 2011; Iley, 2012). Despite
differences, the papers all recommended a combi-
nation of CPS and the use of prognostic indicators.
To define end-stage COPD, clinicians are rec-
ommended to make a clinical holistic assessment by
posing the “Surprise Question”: “Would I be sur-
prised if my patient were to die in the next 12
months?” With patients for whom the answer is
“no,” the time has come to initiate PC.
Different prognostic indicators may support CPS.
Two papers recommended the use of disease-specific
prognostic indicators associated with rapid decline
and worsening health status: severely impaired res-
piratory function (decline in FEV1, dependence on
oxygen therapy, severe dyspnea at rest); frequent ex-
acerbations (frequent hospital admissions, ICU
stay); severe comorbidity; increasing age, weight
loss; and reduced activities of daily living (Seamark
et al., 2007; Trueman & Trueman, 2011). Iley (2012)
recommended adoption of GSF Prognostic Indicator
Guidance (PIG), which recommends use of both gen-
eral and disease-specific indicators of decline and in-
creasing needs.
Holistic Needs Assessment
The findings from one qualitative study (Pinnock
et al., 2011) challenge current assumptions about
the transition to palliative care. The policy of identi-
fying a timepoint for transition to PC is meaningless
and impractical in COPD. COPD is a condition with
no coherent story and an unanticipated end, and
the policy has little resonance for people with
COPD or their clinicians. Rather than looking for a
transition point to switch to PC, their findings pro-
pose linking a holistic assessment of palliative care
needs with milestones throughout the patient’s
journey. Suitable milestones might be: diagnosis,
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retirement on medical grounds, starting long-term
oxygen, hospital admission for an exacerbation, or a
positive answer to the Surprise Question.
General Methods for Early Identification of
Palliative Trajectories (see Table 5)
Illness Trajectories of Functional Decline and
Related Needs
There have been developments in our knowledge of
how functional decline and related needs differ among
different types of progressive illness (Lunney et al.,
2003; Murray et al., 2005). Cancer trajectories are
characterized by steady progression and usually
a clear terminal phase; organ failure trajectories
(COPDandCHF)arecharacterizedbygradualdecline,
punctuated by episodes of acute deterioration and
somerecovery, andsometimesmoresudden, seemingly
unexpected death (Murray et al., 2005). The rationale
is that patients with typical illness trajectories and
their carers seem to have common patterns of experi-
ences, symptoms, and needs as the illness progresses.
Integrated Tools
The PIG is an integrated tool based on prediction of
survival rate and course of decline and increasing
needs (Thomas, 2010; Thomas et al., 2011). It aims
to assist clinicians in identifying adults who are
likely to die within the next 12 months and who
may need additional palliative support. The PIG rec-
ommends that clinicians employ three steps in the
process: (1) the Surprise Question, (2) general indi-
cators of decline, and (3) disease-specific clinical indi-
cators of decline (Thomas et al., 2011). The answer to
the Surprise Question is an intuitive holistic assess-
ment based on clinical experience and a range of
clinical, social, and other factors that give the whole
picture of deterioration. If clinicians are still in
doubt, they may use general indicators of decline
and increasing needs, based on functional, clinical,
therapeutic, and/or biological indicators (Thomas
et al., 2011). To support the assessment, clinicians
may employ functional assessment tools (the Barthel
Index, the PULSE “screening” assessment, or the
Karnofksy Performance Status Score). If still in
doubt, clinicians may utilize disease-specific clinical
indicators developed for a range of diseases, includ-
ing cancer and organ failure (COPD and CHF). Clini-
cal indicators for cancer focus on indicators of rapid
or predictable decline; clinical indicators for COPD
and CHF focus on indicators of erratic decline (Tho-
mas et al., 2011). If the answer is “yes” to one or
more of the indicators, the process is completed with
a needs-based code indicating the remaining lifespan,
the actual clinical situation (described as “stable,” “un-
stable/advanced disease,” “deteriorating,” or “dying”),
and an individual needs assessment.
The Supportive and Palliative Care Indicators
Tool (SPICT), very similar to the PIG (Highet et al.,
2012), is a guide for identifying people at risk of dying
within the next 12 months. Like the PIG, it rec-
ommends indicators to assess the current and future
needs of patients and families. However, the indi-
cators are inverted, starting with general clinical
indicators of decline, followed by disease-specific
clinical indicators of advanced conditions, and,
finally, the Surprise Question.
The Supportive Care Pathway (SCP) is an integra-
ted care pathway based on elements from evidence-
based national (United Kingdom) guidelines (Main
et al., 2006). One reason why the pathway is called
the Supportive Care Pathway is that the generalist
staff tend to associate palliative care with terminal
care. The entry criteria to the pathway are: patients
with a life-limiting illness, admitted to hospital fol-
lowing an acute episode, and not expected to survive
the next 12 months. No formal evaluations have yet
been conducted to assess outcomes for the SCP.
The Centre to Advance Palliative Care (CAPC) has
developed a screening assessment tool to identify
patients at high risk for unmet palliative needs in hos-
pitals (Weissman & Meier, 2011). Its starting point is
identification of patients with any potentially life-lim-
iting or life-threatening disease, disorder, or con-
dition. The screening assessment tool is divided into
two checklists: (1) criteria designed for screening at
the time of admission to hospital, and (2) criteria de-
signed for daily rounds. Each checklist is divided
into primary and secondary criteria to facilitate ease
of implementation. The primary criteria are limited
to the most important indicators, global in nature,
and to be used as the minimum expected standard of
care. The primary criteria at hospital admission are:
the Surprise Question, frequent admissions, admis-
sion prompted by physical or psychological symptoms
that are difficult to control, complex care requirement,
and decline in function. Primary criteria for daily
rounds are: the Surprise Question, physical or psycho-
logical symptomsthat are difficult to control, intensive
care unit stay (.7 days), lack of care goals, disagree-
ment or uncertainty between the patient and staff,
and/or family concern. The secondary criteria are
more specific and comprehensive in scope and include
physical, psychosocial, and spiritual indicators.
Prognostic Score
TheCARINGcriteria area simple set of objectiveprog-
nostic screening criteria applied at the time of hospital
admission to identify patients who have a high likeli-
hood of death within one year and who therefore may
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benefit from palliative care (Fischer et al., 2006). The
criteria for predicting one-year mortality are: cancer
as a primary diagnosis, admissions (2) to the hospi-
tal during the past year for a chronic illness, residence
in a nursing home, intensive care unit admissionwith
multiple organ failure, and noncancer hospice guide-
lines (2 NHPCO criteria). Fischer and colleagues
found that theCARINGcriteriawerehighly predictive
of death at one year in the hospitalized veteran popu-
lation at the time of hospital admission.
Preconditions for Early Integration of
Palliative Care (see Table 6)
There aremethods available to help clinicians identify
patients eligible for palliative care. However, various
barriers in clinicalpracticeneed tobeovercome if early
integration of PC is to succeed (Boyd &Murray, 2010;
Thomas et al., 2011). Our reviewhas identified a num-
ber of barriers that have a decisive impact on early
integration of PC: disease-, staff-, user-, and organiz-
ation-specific, often with inherent interacting factors
documented in cancer, CHF, and COPD populations.
Cancer
Staff-specific: It is an important precondition for the
provision of quality PC that the transition to the pal-
liative phase is identified and explicitly communica-
ted to patient and family (Dalgaard et al., 2010).
Others highlight formulation and communication
about prognosis as a precondition (Maltoni et al.,
2005; Glare & Sinclair, 2008). Communicating prog-
nostic information should be part of a therapeutic al-
liance with the patient (Maltoni et al., 2005).
However, physicians are described as barriers to for-
mulation and communication of prognosis due to
poor prognostic skills, avoidance, and a reluctant ap-
proach (Glare & Sinclair, 2008). Cultivating phys-
icians’ subjective judgment skills in formulating
and communicating prognostic information is crucial
to overcoming barriers of prognostication.
The implementation of the “early integration ap-
proach” is highly dependent on the staff perception
(ormisconception) about PC, which is oftenmistaken
for “terminal care” (Gaertner et al., 2010a; 2011b).
Thus, it is important to ensure that the staff attitude
toward, and culture of, palliative care become an in-
tegral part of patient care.
Organization-specific: There is an urgent need to
facilitate institutionalization of the “early inte-
gration approach” (Gaertner et al., 2011b). Gaertner
and coworkers (2011b; 2012) developed concise defi-
nitions of palliative care assignments and infrastruc-
ture for institutionalization of the “early integration
approach.”
CHF
Disease-specific: The most commonly cited barrier to
providing PC is the unpredictable illness trajectory
and prognostic uncertainty of advanced CHF (Zam-
broski, 2006; Boyd et al., 2009; Green et al., 2010; Sel-
man et al., 2007). Another barrier is the public
perception of CHF as benign compared to cancer (Al-
bert, 2008; Selman et al., 2007).
User-specific: The public perception of CHF as be-
nign may lead to misconceptions at the individual
level (Albert, 2008; Selman et al., 2007). These mis-
conceptions may decrease the threat and burden to
patients and families and provide hope for the future,
but they may lead to fear and anxiety when symp-
toms worsen despite treatment.
Staff-specific: Inadequate communication surround-
ing the transition to PC is a frequently reported barrier
(Green et al., 2010; Barclay et al., 2011; Selman et al.,
2007). The consequence is that end-of-life-care (EoLC)
discussions rarely takeplace at all. The communication
challenges are considerable. The unpredictable illness
trajectory of CHF, prognostic uncertainty, high risk of
sudden death, and compromised patient understand-
ing of their poor prognosis are described as significant
barriers to effective communication. In turn, both
healthcare professionals and patients hold diverse atti-
tudes towards EoLC discussions in terms of preferen-
ces, timing, and content. Lack of adequate
communication skills, an unwillingness to disclose sen-
sitive information, ethical challenges due to prognostic
uncertainty, different patient preferences, and poor
patient understanding underline the need for training
professionals in EoLC communication so that they
might interact with patients effectively. To overcome
barriers of unpredictability, there is a need to shift to
a paradigm of blending active (disease-modifying)
treatment and palliative care (Zambroski, 2006).
Organization-specific: Interdisciplinary coopera-
tion is of great importance in CHF (Albert, 2008;
Green et al., 2010). Collaborative initiatives such as
referral criteria, care pathways, and interdisciplin-
ary education are recommended to facilitate collabor-
ation and enhance themutual understanding of CHF
symptom management and PC between cardiac staff
and PC clinicians.
COPD
Disease-specific: The greatest challenge to the pro-
vision of PC in COPD is prognostic uncertainty due
to the unpredictable illness trajectory and unexpec-
ted death due to acute exacerbation (Seamark et al.,
2007; Spathis & Booth, 2008; Pinnock et al., 2011,
Momen et al., 2012; Iley, 2012).
User-specific: Misconceptions about both COPD
and PC abound and are important barriers. It
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is a sobering thought that patients and caregivers
generally fail to appreciate that COPD is a life-threa-
tening disease (Spathis & Booth, 2008). COPD is de-
scribed as a “way of life” rather than an “illness” that
disrupts life (Pinnock et al., 2011). In our death-deny-
ing culture, PC can be misunderstood as a sign of
“giving up” or that death is imminent (Spathis &
Booth, 2008; Iley, 2012). Thus, discussions about
prognosis may be avoided by patients and family.
Staff-specific: Prognostication in COPD is difficult,
and prognostic uncertaintymay lead to “prognostic pa-
ralysis” (Seamark et al., 2007). Healthcare pro-
fessionals need to overcome these barriers to
prognostic uncertainty in order to provide early PC.
To overcome the challenges caused by the unpredict-
able illness trajectory, improved prognostication and
communication skills are needed (Spathis & Booth,
2008). Inadequate communication surrounding tran-
sitions to PC is a frequently reported barrier (Knauft
et al., 2005; Green et al., 2010; Barclay et al., 2011;Mo-
men et al., 2012; Selman et al., 2007). The unpredict-
able illness trajectory of COPD, prognostic
uncertainty, high risk of sudden death, and compro-
mised patient understanding of the poor prognosis
are significant barriers to effective and timely com-
munication (Green et al., 2010;Barclayet al., 2011, Sel-
man et al., 2007). Furthermore, these barriers foster
uncertainty regarding individual patient attitudes,
preferences, and the timing of EoLC discussions. Ad-
ditionally, healthcare professionals do not identify
EoLC discussions as their responsibility, and many
find it difficult to discuss sensitive subjects such as
poor prognosis and palliative care (Iley, 2012). The con-
sequence is that discussions about EoLC are rare in
COPD (Knauft et al., 2005; Momen et al., 2012).
Good communication skills are a prerequisite to sensi-
tive EoLC discussions, and adequate training in the
breaking of bad news is seen as particularly important
(Spathis & Booth, 2008; Momen et al., 2012). Staff per-
ceptions of palliative culture are also highlighted as a
barrier. A paradigm shift from a disease-oriented ap-
proach to a patient-centered PC approach is central
to delivery of quality PC (Spathis & Booth, 2008).
Organization-specific: Limited resources are men-
tioned as significant barriers to delivery of PC (Spa-
this & Booth, 2008). In particular, interdisciplinary
training and education are called for. Respiratory
specialists require training in the skills of PC, and
PC specialists needmore information about theman-
agement of nonmalignant disease.
Outcomes for Patients and Relatives (see
Table 7)
This section deals with the outcome of early inte-
gration of palliative care as it affects patients and
relatives. Many studies have reported a positive cor-
relation between early integration and high-quality
PC (Murray et al., 2005; Boyd & Murray, 2010; Tho-
mas et al., 2011). However, there is sparse evidence
supporting such statements, and the evidence in-
cludes only cancer populations.
A study among patients with newly diagnosed me-
tastatic non-small-cell lung cancer (NSCLC) demon-
strated that early integration of PC led to significant
improvements in both quality of life (QoL) and mood,
and prolonged survival by approximately twomonths
(Temel et al., 2010). It was hypothesized that im-
provements in QoL and depressed mood may account
for the observed survival benefit. The study conclu-
ded that early integration of PC with standard oncol-
ogy for patients with NSCLC may result in better
symptom management, leading to prolonged survi-
val and better QoL.
Another study explored NSCLC patients’ under-
standing of the prognosis and goals of cancer therapy,
the effect of early PC on patients’ illness perception,
and the impact of medical decision making at the
end of life (Temel et al., 2011). Many patients with
newly diagnosed metastatic NSCLC held inaccurate
perceptions of their prognoses. However, early PC
was found to significantly improve patients’ under-
standing of prognosis over time, and changes of per-
ception were significantly linked to treatment
decisions and less aggressive end-of-life care.
A study examined the association between EoLC
discussions with physicians and the medical care
patients with advanced cancer receive near death,
patients’ psychological distress, quality of life near
death, and caregiver bereavement (Wright et al.,
2008). EoLCdiscussionswere found to be significantly
associated with less aggressive medical care near
death and earlier hospice referrals, leading to better
QoLneardeath.BetterQoLnear deathwasassociated
with better QoL among surviving caregivers, who ex-
perienced less regret and showed improvements in
self-reported health, physical functioning, mental
health, and overall QoL during the bereavement
period. Despite physicians’ concern that EoLC discus-
sions may cause psychological harm, the study repor-
ted no evidence that these discussions were
significantly associated with increased emotional dis-
tress or psychiatric disorders. Instead, the worst out-
comes were seen in patients who did not report
having EoLC discussions.
DISCUSSION
This systematic review has identified a number of
disease-specific and general methods for early identi-
fication of patients with cancer, CHF, and COPDwho
may benefit from early palliative care. However, a
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number of interacting disease-, staff-, user-, and or-
ganization-specific barriers need to be overcome if
early integration of PC is to succeed. Early inte-
gration of PC may lead to better symptom manage-
ment, prolonged survival, and better quality of life.
However, the outcome of early integration of PC
has only been examined in cancer populations and
among cancer patients receiving specialized PC. We
now summarize and discuss the methods for early
identification, preconditions, and outcomes.
Disease-Specific Methods
In cancer populations, disease-specific methods for
EI of palliative trajectories include the prognostica-
tion of advanced cancer, diagnosis-specific clinical
assessment, and clinical holistic screening. Despite
variation in the accuracy of physicians’ judgment,
all papers recommend that CPS be combined
with prognostic scores, prognostic indicators, and/
or biological parameters—all objective indicators of
patient-related physical symptoms. The prognostic
capacity of patient-reported subjective indicators as
psychological distress is uncertain. Prognostic indi-
cators have different meaning and relevance in
terminal, far-advanced, advanced, and less-ad-
vanced disease. Palliative trajectories have been
identified using prognostic factors relevant for ad-
vanced cancer (life expectancy 3–12 months). The
controversy about confusion and dyspnea has also
been identified.
Gaertner et al. (2011b) recommended diagnosis
and stage-specific objective clinical criteria to ident-
ify patients with incurable, progressive, and life-lim-
iting disease. Their criteria included tumor-related
indicators typical for less-advanced disease, indicat-
ing earlier identification of palliative trajectories
than recommended above. However, the criteria still
remain to be evaluated in larger and diverse cancer
populations.
The NCCN guidelines recommend screening
based on more extensive and holistic screening cri-
teria, which include individual clinical judgment, ob-
jective prognostic indicators, and physical and
psychosocial symptom burden or needs.
In CHF populations, disease-specific methods for
EI of palliative trajectories include prognostication,
an integrated approach, and symptom assessment.
Prognostication in CHF focuses on identifying end-
stage CHF patients who could benefit from PC. One
review recommended subjective and objective clini-
cal assessment based on prognostic factors as the
best methods so far. Other studies focused on prog-
nostic tools to predict survival on the basis of objec-
tive variables. However, such models fall short of
predicting individual end-stage CHF. Patient-predic-
ted self-assessment of life expectancy is not superior
to model-predicted life expectancy. Studies of prog-
nostication in CHF are calling for further validation
in prospective studies within larger andmore diverse
populations to strengthen validity and generalizabil-
ity. The European Society of Cardiology (ESC ) rec-
ommended a combination of objective criteria and
clinical judgment as triggers for integration of pallia-
tive care for CHF patients with progressive disease
(NYHA III-IV).
An integrated approach recommends integration
of PC based on diagnosis of advanced CHF and care
needs. This approach places greater emphasis on
how the patient trajectory is displayed rather than
exact prognostication and takes into account that
sudden death can occur at any time, and during
any phase. The use of an integrated approach in daily
clinical practice is still to be evaluated.
The effectiveness of symptom assessment as an
approach to early integration of PC is uncertain.
The PPS and ESAS screening questionnaires may
supplement traditional CHF questionnaires, but fur-
ther validation is needed.
In COPD populations, specific methods for EI in-
clude prognostication of end-stage COPD and holistic
needs assessment. Three papers linked the tran-
sition to PC and identification of end-stage COPD
(life expectancy .12 months). Prognostication of
end-stage COPD is based on clinical holistic assess-
ment, supported by clinical prognostic indicators.
Two papers recommended the use of disease-specific
clinical indicators, while another recommended
adoption of the PIG, which employs both general
and disease-specific clinical indicators. The PIG is
more extensive in scope and number of indicators
than the methods recommending disease-specific in-
dicators. Due to the known difficulties with prognos-
tication of COPD, more formal evaluation of these
methods is recommended.
A single qualitative study was critical to the policy
of identifying the timepoint for transition to PC care,
as this may lead to prognostic paralysis and exces-
sively late referral. This paper proposed linking the
holistic assessment of PC needs with key disease
milestones throughout the patient’s journey, but the
implications for daily clinical practice are still to be
investigated.
GENERAL METHODS
Three general methods have been described for
identification of palliative trajectories: the trajectory
approach, integrated tools, and a prognostic tool.
Common to all threemethods is an emphasis on prog-
nostication based on an assessment of functional de-
cline and related needs.
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The trajectory approach combines patterns of
functional decline and related needs related to differ-
ent types of progressive illness. The trajectory ap-
proach gives a conceptual overview, but it may be
less helpful with a specific individual patient due to
interpatient variation in terms of rate of decline
and progression, risk of sudden death, and comorbid-
ity. More research is needed to help understand how
insights offered by these trajectories can be transla-
ted into daily clinical practice. However, considering
these trajectories may increase “professional aware-
ness of dying” and lead to integration of palliative
care at an earlier stage than would otherwise be
the case. The trajectory approach relates to physical
well-being. Trajectories related to the spiritual/exis-
tential, social, and psychological domains are not
mapped. These domains may affect the illness trajec-
tories and have different courses (Grant et al., 2010):
Specific integrated screening tools are recom-
mended: the PIG, SPICT, and SCP tool developed in
the United Kingdom and the CAPC tool developed
in the United States. The UK screening tools
recommend prediction of survival (life expectancy
.12 months) as a criterion for potential entry into
a PC pathway. The PIG and SPICT tools are very
similar. They recommend three triggers to assess
the rate and course of decline and the increasing
needs of patients and their families: holistic clinical
expertise, and general- and disease-specific clinical
indicators. The PIG tool is more extensive in scope
than the SPICT tool, especially regarding clinical in-
dicators. The main difference is that the SPICT tool
inverts the triggers, an expression of clinical indi-
cators having priority over clinical expertise. The
SPICT tool is presented in a one-page format. Com-
bined with fewer clinical indicators, it may be less
complicated to use in daily clinical practice. Evalu-
ation of the tool is in progress. The PIG has under-
gone extensive evaluation; however, its acceptance
by patients and families has not yet been evaluated.
The SCP is a holistic measure addressing all aspects
of care, including pathway entry criteria. The SCP
has not yet undergone formal evaluation, so that
the effect of labeling a pathway “supportive” rather
than “palliative” is uncertain.
The CASP tool is somewhat different from the UK
tools. The CASP tool recommends identification of
patients at high risk for unmet palliative care needs
in hospitals. The target group for screening is
patients with any potentially life-limiting or life-
threatening disease, disorder, or condition—a broad
and yet inclusive construct open to variable in-
terpretation. The formulation of criteria for use at
hospital admission and for daily rounds ensures con-
tinuous, dynamic screening. The criteria are a targe-
ted assessment of care needs rather than functional
decline assessed by the use of clinical indicators.
Both primary and secondary criteria are holistic in
scope, including assessment of the physical, psycho-
social, and spiritual needs of the patient and family.
One study (Fischer et al., 2006) developed a
screening tool called the CARING criteria, a predic-
tor of one-year mortality, applied at the time of hospi-
tal admission and based on objective prognostic
indicators. The CARING criteria were found to be
highly predictive of death at one year in a hospital-
ized veteran population at the time of hospital admis-
sion; however, the veteran population is unique (98%
male), and the results cannot be applied to a more di-
verse hospitalized population without further vali-
dation.
BARRIERS TO EARLY INTEGRATION OF
PALLIATIVE CARE
For cancer, staff-specific barriers to early integration
of PC are particularly highlighted. The poor prognos-
tic skills of physicians and their reluctant attitude
toward communication of prognostic information to
patient and family, as well as staff misconceptions
about PC as “terminal care,” arementioned as impor-
tant barriers for the “early integration approach.”
The papers reviewed do not assign particular atten-
tion to disease- and user-specific factors.
For CHF and COPD, a number of similar disease-,
staff-, and user-specific barriers form part of a mu-
tually fortifying dynamic process, making it difficult
to overcome the identified barriers. The following
barriers are part of this process: unpredictable ill-
ness trajectory, risk of sudden death, prognostic un-
certainty, the public perception of CHF and COPD
as benign, compromised patient understanding of
their poor prognosis, and a lack of effective communi-
cation about EoLC issues combined with a lack of
adequate professional communication skills and un-
willingness to disclose sensitive information. Inter-
disciplinary cooperation is of vital importance in
enhancing cooperativework andmutual understand-
ing of CHF/COPD symptommanagement and pallia-
tive care.
OUTCOME FOR PATIENTS AND
RELATIVES
Two studies based on randomized controlled trials
among patients with non-small-cell lung cancer car-
ried out by Temel and coworkers (2010; 2011) conclu-
ded that early integration of PC with standard
oncologymay result in better symptommanagement,
prolonged survival, better QoL, improved patient
perception of prognosis, and less aggressive care at
the end of life. However, these studies examined the
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effect of specialized PC, not general PC. Wright and
colleagues (2008) found that integration of PC com-
bined with EoLC discussions among patients with
advanced cancer and their caregivers was signifi-
cantly associated with less aggressive medical care
and better QoL near death, as well as better QoL
among surviving caregivers.
STRENGTHS AND LIMITATIONS OF THE
STUDY
To the best of our knowledge, the present study is the
first systematic review to synthesize the literature
concerning early integration of palliative care for
patients with both malignant and nonmalignant dis-
eases and their families. We consider it a strength
that it was built around the best available knowledge
in the area, scientific studies, reviews, and clinical
guidelines. It provides an overview of the knowledge
and recommendations established on the topic so far,
indicating gaps and controversy in evidence-based
knowledge, and areas of improvement to support im-
plementation of the “early integration approach” in
daily clinical practice.
However, the study does have its limitations. The
implicit exclusion criteria may have created a publi-
cation bias. The scope of included populations and
the aims of the study, combined with an intention
to select a potentially workable and homogeneous
sample, led to exclusion of non-Western locations
and papers written in languages other than English
(apart from those written in Scandinavian tongues).
The search strategy covers the period from 2002,
when WHO formulated the “early integration ap-
proach.” Thus, potential relevant papers dated before
2002 are not included. However, more of the papers
included are built on knowledge acquired prior to
2002. The study focuses on general hospitals.We can-
not exclude the possibility that there is relevant
knowledge about early integration of PC in other set-
tings, and in specialized PC relevant to hospitals.
While the search strategy was difficult to create, it
appears to have been effective, as it was completed by
searching the reference lists and citations of included
papers. We attempted to reduce the selection bias
through the use of objective, reproducible criteria to
select relevant publications and assess their validity.
FUTURE DIRECTIONS
This review has identified some of the key issues im-
portant to early integration of general palliative care
in hospitals for patients with cancer, CHF, and
COPD. A number of disease-specific and general
methods for EI of palliative trajectories have been
identified. Prognostication of end-stage disease
based on (holistic) clinical judgment, different prog-
nostic factors, and/or care needs are the most fre-
quently recommended methods for both malignant
and nonmalignant disease. However, this review
highlights the controversy and gaps in knowledge re-
garding methods for EI of palliative trajectories.
There is disagreement as to when a palliative trajec-
tory begins. The prognostic models typically take as
the starting point when the patient has less than
12 months of life remaining. Others are critical of
the use of definite timescales, as that may lead to re-
ferrals to PC being made too late. These models rec-
ommend referral criteria based on definitions of a
potential palliative patient followed by symptom
assessment or (holistic) needs assessment. This ap-
proach takes into account that PC for cancer patients
may be relevant in less advanced stages and, in terms
of CHF and COPD, takes into account the risk of sud-
den death, acute exacerbations, and illness experi-
ences. So far, there is sparse evidence of methods to
support this intention.
There is also disagreement about specific clinical
indicators and prioritization of the disease-specific
and general indicators of end-stage disease, indicat-
ing that no prognostic model presented in our review
can be recommended for routine clinical use without
further validation. However, the prognostic models
are the best-evaluated instruments, compared to in-
struments based on holistic symptoms or needs as-
sessment. There is an urgent need to develop and
evaluate methods based on holistic symptom or
needs assessment, as they aremore inclusive in scope
and criteria and may lead to earlier referral to PC
than prognostic models.
The papers reviewed here typically report on refer-
ral criteria based on objective clinical indicators or
physical functioning. Referral criteria based on sub-
jective patient-reported indicators have not been ex-
tensively investigated. Very few methods include
psychological, social, and existential factors and the
perspective of relatives as referral criteria. These
factors may be relevant indicators of early inte-
gration of PC.
We have identified a number of barriers to the
“early integration approach,” most comprehensively
regarding nonmalignant diseases. The early integra-
tion approach may cause growing tension between
active management and the need to communicate
an uncertain or poor prognosis. This is a doublemess-
age that is difficult for clinicians to communicate and
for patients and families to receive. There is an
urgent need for training, education, and collabora-
tive initiatives targeted at clinicians in order to over-
come barriers and facilitate implementation of the
“early integration approach” in daily clinical prac-
tice. Our review shows that acceptance of the “early
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integration approach” by patients and relatives var-
ies widely. Thus, more research about this area is rec-
ommended.
The evidence on the effect of early integration of
general palliative care in hospitals is sparse. So far,
outcomes have been examined in particular in
specific cancer populations and among lung cancer
patients receiving specialized PC. Further research
should be conducted on outcomes in cancer, COPD,
and CHF populations to overcome gaps in knowledge
and underpin changes in future clinical practice.
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